Medicine | Dose and frequency | N of cases |
---|---|---|
2mg daily | 2 | |
5 mg daily | 2 | |
5mg once to three times weekly | 5 | |
5 mg twice monthly | 1 | |
25 mg once daily | 7 | |
100 mg once daily | 1 | |
400 mg once daily | 1 | |
150 mg once daily | 8 | |
300 mg once daily | 1 | |
25 mg once daily | 4 | |
25 mg two to three times daily | 2 |
Characteristic | |
---|---|
• Male | 266 (42.8%) |
• Female | 356 (57.2%) |
77.2 (±6.2) | |
• Range (years) | 65-101 |
5.6 (±2.9) | |
374 (60.1%) |
Anticholinergic burden (score) | N (%) of patients with anticholinergic medicines |
---|---|
54 (69.2%) | |
19 (24.4%) | |
4 (5.1%) | |
1 (1.3%) |
Medicine (ATC code) | N (%) of patients with anticholinergic burden N=78 | % of all enrolled patients N=622 | Anticholinergic burden |
---|---|---|---|
41 (52.6%) | 6.6% | ||
Diazepam (N05BA01) | 10 (12.8%) | 1.6% | 1 |
Quetiapine (N05AH04) | 9 (11.5%) | 1.4% | 1 |
Paroxetine (N06AB05) | 7 (9.0%) | 1.1% | 1 |
Amitriptilyne (N06AA09) | 6 (7.7%) | 1.0% | 2 |
Mirtazapine (N06AX11) | 4 (5.1%) | 0.6% | 1 |
Citalopram (N06AB04) | 4 (5.1%) | 0.6% | 1 |
Fentanyl (N02AB03) | 2 (2.6%) | 0.3% | 1 |
Olanzapine (N05AH03) | 2 (2.6%) | 0.3% | 1 |
Carbamazepine (N03AF01) | 2 (2.6%) | 0.3% | 1 |
Fluoxetine (N06AB03) | 2 (2.6%) | 0.3% | 1 |
Risperidone (N05AX08) | 2 (2.6%) | 0.3% | 1 |
Promazine (N05AA03) | 1 (1.3%) | 0.2% | 1 |
Clozapine (N05AH02) | 1 (1.3%) | 0.2% | 2 |
Lithim (N05AN01) | 1 (1.3%) | 0.2% | 1 |
Trazodone (N06AX05) | 1 (1.3%) | 0.2% | 1 |
11 (14.1%) | 1.8% | ||
Ranitidine (A02BA02) | 8 (10.3%) | 1.3% | 1 |
Domperidone (A03FA03) | 3 (3.8%) | 0.5% | 1 |
11 (14.1%) | 1.8% | ||
Loratadine (R06AX13) | 4 (5.1%) | 0.6% | 1 |
Cetirizine (R06AE07) | 3 (3.8%) | 0.5% | 1 |
Fexofenadine (R06AX26) | 2 (2.6%) | 0.3% | 1 |
Theophylline (R03DA04) | 2 (2.6%) | 0.3% | 1 |
6 (7.7%) | 1.0% | ||
Tizanidine (M03BX02) | 6 (7.7.%) | 1.0% | 2 |
5 (6.4%) | 0.8% | ||
Darifenacin (G04BD10) | 3 (3.8%) | 0.5% | 2 |
Tolterodine (G04BD07) | 2 (2.6%) | 0.3% | 2 |
1 (1.3%) | 0.2% | ||
Disopyramide (C01BA03) | 1 (1.3%) | 0.2% | 1 |